Iñiguez Germán, Ong Ken, Peña Veronica, Avila Alejandra, Dunger David, Mericq Veronica
Institute of Maternal and Child Research, University of Chile, Santiago, Chile.
J Clin Endocrinol Metab. 2002 Dec;87(12):5830-3. doi: 10.1210/jc.2002-021206.
Wide ranges in postnatal weight gain are seen in infants born small for gestational age (SGA); most show some catch-up growth and this may be driven by increased appetite. Ghrelin, the natural ligand of the GH secretagogue receptor, has potent orexigenic effects. In adults circulating ghrelin levels are increased in anorexia, decreased in obesity and show post prandial suppression. The aim of the present study was to test the hypothesis that rate of weight gain over the first year in SGA infants may relate to variable suppression of circulating ghrelin levels. Serum ghrelin levels were measured in 1 y old infants born SGA (n = 85) and in control infants born adequate for gestatitional age (AGA) (n = 22) fasting and 10 minutes after intravenous (iv) glucose (0.5 g/Kg of 25% dextrose). Sex- and gestational age-adjusted SD scores (SDS) for body weight were calculated at birth and at 1 y, and delta weight SDS between 0-1 y was calculated as an index of postnatal weight gain. In both SGA and AGA groups, ghrelin levels reduced from fasting (mean +/- SE: 104.4 +/- 6.4 fmol/ml) to 10 minutes post-iv glucose (82.7 +/- 5.3, p < 0.005). There were no differences in ghrelin levels between SGA and AGA infants (fasting or post-iv glucose). However, in SGA infants ghrelin levels post-glucose, but not fasting, were psitively related to current length (r = 0.28, p < 0.05), weight (r = 0.23, p < 0.05) and to change in weight SDS 0-1 y (r = 0.22, p < 0.05). SGA infants who showed poor catch-up growth showed a larger decline in ghrelin concentrations post-iv glucose. In conclusion, circulating ghrelin levels rapidly decreased after iv glucose. Higher ghrelin levels or lower reductions in circulating levels following iv glucose were seen in SGA infants who showed greater infancy weight gain, suggesting that sustained orexigenic drive could contribute to postnatal catch-up growth.
小于胎龄儿(SGA)出生后的体重增加范围很广;大多数表现出一定程度的追赶生长,这可能是由食欲增加驱动的。胃饥饿素是生长激素促分泌素受体的天然配体,具有强大的促食欲作用。在成年人中,厌食症患者循环中的胃饥饿素水平升高,肥胖者降低,且进食后会受到抑制。本研究的目的是检验以下假设:SGA婴儿出生后第一年的体重增加率可能与循环胃饥饿素水平的可变抑制有关。对85名SGA出生的1岁婴儿和22名适于胎龄(AGA)出生的对照婴儿在空腹时以及静脉注射(iv)葡萄糖(0.5 g/Kg的25%葡萄糖)10分钟后测量血清胃饥饿素水平。计算出生时和1岁时根据性别和胎龄调整的体重标准差评分(SDS),并计算0至1岁之间的体重SDS差值作为出生后体重增加的指标。在SGA组和AGA组中,胃饥饿素水平从空腹时(平均±标准误:104.4±6.4 fmol/ml)降至静脉注射葡萄糖后10分钟(82.7±5.3,p<0.005)。SGA婴儿和AGA婴儿之间胃饥饿素水平(空腹或静脉注射葡萄糖后)没有差异。然而,在SGA婴儿中,葡萄糖注射后而非空腹时的胃饥饿素水平与当前身长(r=0.28,p<0.05)、体重(r=0.23,p<0.05)以及0至1岁体重SDS的变化(r=0.22,p<0.05)呈正相关。追赶生长不佳的SGA婴儿静脉注射葡萄糖后胃饥饿素浓度下降幅度更大。总之,静脉注射葡萄糖后循环胃饥饿素水平迅速下降。在婴儿期体重增加较多的SGA婴儿中,静脉注射葡萄糖后胃饥饿素水平较高或循环水平下降幅度较小,这表明持续的促食欲驱动力可能有助于出生后的追赶生长。